🇺🇸 FDA
Patent

US 9018210

Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation

granted A61KA61K31/192A61K31/235

Quick answer

US patent 9018210 (Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation) held by The Regents of the University of California expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/192, A61K31/235, A61K31/41, A61K31/416